Prognostic Significance of Different Endoscopic Scores in Post-Operative Crohn&apos;s Disease and their Role in Patients with Low-Risk Features

Inflammatory Bowel Disease

Corticosteroid-sparing effects of risankizumab versus ustekinumab in patients with moderately to severely active Crohn's disease: post hoc results from the phase 3b SEQUENCE trial

J Crohns Colitis

Raine T, Danese S, Schreiber S, Gao X, Hanauer S, Torres J, Cunneen C, Kligys K, Huang X, Garrison A, Neimark E, Anschutz T, Crowley J, Cross RK

doi: 10.1093/ecco-jcc/jjag104

Inflammatory Bowel Disease

Retention of the ileocolic pedicle correlates with higher postoperative endoscopic recurrence risk in Crohn's disease ileocolic resection

J Crohns Colitis

Zhang C, Liu G, Bi J, Fu J, Tu Q, Zhou C, Duan M, Cao L, Peng L, Ding Z, Li Y

doi: 10.1093/ecco-jcc/jjag116

Inflammatory Bowel Disease

Patients with Crohn's disease achieving transmural healing experience superior long-term outcomes compared with those with endoscopic or radiologic healing alone

Inflamm Bowel Dis

Vuyyuru SK, Goodwin SW, Solitano V, Ramsewak D, Kassam Z, Townsend C, Gregor J, Beaton M, Crowley E, Alkhattabi M, Sey M, Jairath V

doi: 10.1093/ibd/izag114

Inflammatory Bowel Disease

An Enhanced Treatment Algorithm Targeting Mucosal Healing is Effective and Safe in Older Patients with Crohn's Disease: A Post-hoc Analysis of the REACT2 Trial

Am J Gastroenterol

Goodwin SW, Vuyyuru SK, Sedano R, Zou G, Dulai PS, Singh S, Narula N, Ma C, Jairath V

doi: 10.14309/ajg.0000000000004015

Inflammatory Bowel Disease

Magnetic resonance imaging-based simplified MaRIA scores are associated with future surgery in Crohn's disease, but modest correlation with ileo-colonoscopic inflammation limits their utility in clinical trials: results from the PROFILE trial

J Crohns Colitis

Bhandari M, Sharip MT, Noor NM, Khwaja S, Paverd H, De Paepe KN, Godfrey E, Hickman K, Patel KV, Subramanian S, Raine T, Lee JC, Kennedy NA, Upponi S, Parkes M, PROFILE Study Group

doi: 10.1093/ecco-jcc/jjag056

Inflammatory Bowel Disease

Therapeutic Benefit of Upadacitinib in Severe Post-Proctectomy (Class 4) Perianal Crohn's Disease: A Three-Patient Case Series

Inflamm Bowel Dis

Hanna LN, Quraishi B, Pelly T, Lung P, Tozer P, Hart A, Wong SY, Powell N

doi: 10.1093/ibd/izaf216

Inflammatory Bowel Disease

Efficacy and Safety of Risankizumab in Patients with Moderately to Severely Active Crohn's Disease: Interim Results from the SEQUENCE Open-Label Extension Study

J Crohns Colitis

Peyrin-Biroulet L, Atreya R, Danese S, Lindsay JO, Chapman JC, Anschutz T, Huang X, Zambrano J, van Haaren S, Joshi N, Duan WR, Cross RK

doi: 10.1093/ecco-jcc/jjaf213

Inflammatory Bowel Disease

Integrating Intestinal Ultrasound to Clinical Trials in Patients With Crohn's Disease: Opportunities and Challenges

Inflamm Bowel Dis

Jairath V, Adsul S, Allocca M, Danese S, Dubinsky MC, de Oliveira MF, Ma C, Kucharzik T, Novak KL, Panaccione R, Bautista IR, Sands BE, Taylor SA, Wilkens R, Maaser C

doi: 10.1093/ibd/izaf196

Inflammatory Bowel Disease

Ustekinumab therapy for moderately to severely active pediatric Crohn's disease: UNITI Jr study safety and efficacy results in patients weighing at least 40 kg

J Crohns Colitis

De Greef E, Turner D, Kierkuś J, Korczowski B, Meglicka M, Cohen SA, Hyams JS, Griffiths AM, Rosh JR, Strauss R, Van Limbergen E, Adedokun OJ, Kim L, Volger S, UNITI Jr study Group

doi: 10.1093/ecco-jcc/jjag011

Gastroenterology

Prognostic Significance of Different Endoscopic Scores in Post-Operative Crohn's Disease and their Role in Patients with Low-Risk Features

Related content

Corticosteroid-sparing effects of risankizumab versus ustekinumab in patients with moderately to severely active Crohn's disease: post hoc results from the phase 3b SEQUENCE trial

Retention of the ileocolic pedicle correlates with higher postoperative endoscopic recurrence risk in Crohn's disease ileocolic resection

Patients with Crohn's disease achieving transmural healing experience superior long-term outcomes compared with those with endoscopic or radiologic healing alone

An Enhanced Treatment Algorithm Targeting Mucosal Healing is Effective and Safe in Older Patients with Crohn's Disease: A Post-hoc Analysis of the REACT2 Trial

Magnetic resonance imaging-based simplified MaRIA scores are associated with future surgery in Crohn's disease, but modest correlation with ileo-colonoscopic inflammation limits their utility in clinical trials: results from the PROFILE trial

Therapeutic Benefit of Upadacitinib in Severe Post-Proctectomy (Class 4) Perianal Crohn's Disease: A Three-Patient Case Series

Efficacy and Safety of Risankizumab in Patients with Moderately to Severely Active Crohn's Disease: Interim Results from the SEQUENCE Open-Label Extension Study

Integrating Intestinal Ultrasound to Clinical Trials in Patients With Crohn's Disease: Opportunities and Challenges

Ustekinumab therapy for moderately to severely active pediatric Crohn's disease: UNITI Jr study safety and efficacy results in patients weighing at least 40 kg